Evolucion de la prevalencia de la infeccion por Mycobacterium tuberculosis en una poblacion reclusa al ingreso en prision entre 1991 y 1996

Translated title of the contribution: Evolution of the prevalence of infection of Mycobacterium tuberculosis in a penitentiary population on admission to prison from 1991 to 1996

Vicente Martín, Joan A. Cayla, Angela Bolea, José A. De Paz

Research output: Contribution to journalArticle

Abstract

Background: In Spanish prisons tuberculosis is a serious problem of public health. The analysis of temporal trends of tuberculous infection can show the effectiveness of interventions developed. Patients, Material and Methods: All admissions in a prison between July 1991 and June 1996, without antecedents of chemotherapy or chemoprophylaxis, were included. We gathered socio-demographic variables as well as prison-related variables and HIV-risk factors. Tuberculin skin test was performed with 2 U of PPD RT-23 following the Spanish Consensus to Criterion of Tuberculous Infection. Statatistic analysis was based on multivariate analysis (logistics regression). Results: 37% of 1,459 prisoners analyzed were infected with M. tuberculosis. The tuberculous infection was more frequent among older prisoners (p <0.001) and those with more time spent in prison (p <0.001). Those with BCG-vaccination showed lesser levels of tuberculin reaction (p = 0.001). Temporal trends of tuberculous infection didn't show variations, but in intravenous drug users IVDU (p = 0.012) and those with time spent in prison (p = 0.08) it was increased. Conclusions: We detected a high prevalence of tuberculous infection and the time spent in prison was one of the risk factors. The infection was probably underestimate among those with BCG-vaccination because of the criterion used. The tuberculous infection was increased among IVDU and those with antecedent of time spent in prison.

Original languageSpanish
Pages (from-to)11-16
Number of pages6
JournalMedicina clínica
Volume111
Issue number1
StatePublished - Jun 13 1998
Externally publishedYes

Fingerprint

Prisons
Mycobacterium tuberculosis
Infection
Population
Prisoners
Tuberculin
Mycobacterium bovis
Vaccination
Tuberculin Test
Chemoprevention
Drug Users
Skin Tests
Tuberculosis
Multivariate Analysis
Public Health
Logistic Models
Demography
HIV
Drug Therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Evolucion de la prevalencia de la infeccion por Mycobacterium tuberculosis en una poblacion reclusa al ingreso en prision entre 1991 y 1996. / Martín, Vicente; Cayla, Joan A.; Bolea, Angela; De Paz, José A.

In: Medicina clínica, Vol. 111, No. 1, 13.06.1998, p. 11-16.

Research output: Contribution to journalArticle

Martín, Vicente ; Cayla, Joan A. ; Bolea, Angela ; De Paz, José A. / Evolucion de la prevalencia de la infeccion por Mycobacterium tuberculosis en una poblacion reclusa al ingreso en prision entre 1991 y 1996. In: Medicina clínica. 1998 ; Vol. 111, No. 1. pp. 11-16.
@article{53a3dedf94d54109b375b15024414475,
title = "Evolucion de la prevalencia de la infeccion por Mycobacterium tuberculosis en una poblacion reclusa al ingreso en prision entre 1991 y 1996",
abstract = "Background: In Spanish prisons tuberculosis is a serious problem of public health. The analysis of temporal trends of tuberculous infection can show the effectiveness of interventions developed. Patients, Material and Methods: All admissions in a prison between July 1991 and June 1996, without antecedents of chemotherapy or chemoprophylaxis, were included. We gathered socio-demographic variables as well as prison-related variables and HIV-risk factors. Tuberculin skin test was performed with 2 U of PPD RT-23 following the Spanish Consensus to Criterion of Tuberculous Infection. Statatistic analysis was based on multivariate analysis (logistics regression). Results: 37{\%} of 1,459 prisoners analyzed were infected with M. tuberculosis. The tuberculous infection was more frequent among older prisoners (p <0.001) and those with more time spent in prison (p <0.001). Those with BCG-vaccination showed lesser levels of tuberculin reaction (p = 0.001). Temporal trends of tuberculous infection didn't show variations, but in intravenous drug users IVDU (p = 0.012) and those with time spent in prison (p = 0.08) it was increased. Conclusions: We detected a high prevalence of tuberculous infection and the time spent in prison was one of the risk factors. The infection was probably underestimate among those with BCG-vaccination because of the criterion used. The tuberculous infection was increased among IVDU and those with antecedent of time spent in prison.",
author = "Vicente Mart{\'i}n and Cayla, {Joan A.} and Angela Bolea and {De Paz}, {Jos{\'e} A.}",
year = "1998",
month = "6",
day = "13",
language = "Spanish",
volume = "111",
pages = "11--16",
journal = "Medicina Clinica",
issn = "0025-7753",
publisher = "Ediciones Doyma, S.L.",
number = "1",

}

TY - JOUR

T1 - Evolucion de la prevalencia de la infeccion por Mycobacterium tuberculosis en una poblacion reclusa al ingreso en prision entre 1991 y 1996

AU - Martín, Vicente

AU - Cayla, Joan A.

AU - Bolea, Angela

AU - De Paz, José A.

PY - 1998/6/13

Y1 - 1998/6/13

N2 - Background: In Spanish prisons tuberculosis is a serious problem of public health. The analysis of temporal trends of tuberculous infection can show the effectiveness of interventions developed. Patients, Material and Methods: All admissions in a prison between July 1991 and June 1996, without antecedents of chemotherapy or chemoprophylaxis, were included. We gathered socio-demographic variables as well as prison-related variables and HIV-risk factors. Tuberculin skin test was performed with 2 U of PPD RT-23 following the Spanish Consensus to Criterion of Tuberculous Infection. Statatistic analysis was based on multivariate analysis (logistics regression). Results: 37% of 1,459 prisoners analyzed were infected with M. tuberculosis. The tuberculous infection was more frequent among older prisoners (p <0.001) and those with more time spent in prison (p <0.001). Those with BCG-vaccination showed lesser levels of tuberculin reaction (p = 0.001). Temporal trends of tuberculous infection didn't show variations, but in intravenous drug users IVDU (p = 0.012) and those with time spent in prison (p = 0.08) it was increased. Conclusions: We detected a high prevalence of tuberculous infection and the time spent in prison was one of the risk factors. The infection was probably underestimate among those with BCG-vaccination because of the criterion used. The tuberculous infection was increased among IVDU and those with antecedent of time spent in prison.

AB - Background: In Spanish prisons tuberculosis is a serious problem of public health. The analysis of temporal trends of tuberculous infection can show the effectiveness of interventions developed. Patients, Material and Methods: All admissions in a prison between July 1991 and June 1996, without antecedents of chemotherapy or chemoprophylaxis, were included. We gathered socio-demographic variables as well as prison-related variables and HIV-risk factors. Tuberculin skin test was performed with 2 U of PPD RT-23 following the Spanish Consensus to Criterion of Tuberculous Infection. Statatistic analysis was based on multivariate analysis (logistics regression). Results: 37% of 1,459 prisoners analyzed were infected with M. tuberculosis. The tuberculous infection was more frequent among older prisoners (p <0.001) and those with more time spent in prison (p <0.001). Those with BCG-vaccination showed lesser levels of tuberculin reaction (p = 0.001). Temporal trends of tuberculous infection didn't show variations, but in intravenous drug users IVDU (p = 0.012) and those with time spent in prison (p = 0.08) it was increased. Conclusions: We detected a high prevalence of tuberculous infection and the time spent in prison was one of the risk factors. The infection was probably underestimate among those with BCG-vaccination because of the criterion used. The tuberculous infection was increased among IVDU and those with antecedent of time spent in prison.

UR - http://www.scopus.com/inward/record.url?scp=0032513981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032513981&partnerID=8YFLogxK

M3 - Article

VL - 111

SP - 11

EP - 16

JO - Medicina Clinica

JF - Medicina Clinica

SN - 0025-7753

IS - 1

ER -